Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
Ying Li, Ju Zhang, Jie Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12

Showing 12 citing articles:

Novel PdPtCu Nanozymes for Reprogramming Tumor Microenvironment to Boost Immunotherapy Through Endoplasmic Reticulum Stress and Blocking IDO‐Mediated Immune Escape
Yulin Xie, Man Wang, Yanrong Qian, et al.
Small (2023) Vol. 19, Iss. 44
Closed Access | Times Cited: 36
Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment
Ying Li, Wenjing Zhao, Yanli Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer
Ying Li, Jing Wang, Haiyan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
Manoj Amrutkar, Kjersti Berg, Aina Balto, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Metabolic vulnerabilities in cancer: A new therapeutic strategy
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El-Tanani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104438-104438
Closed Access | Times Cited: 3
The preclinical gap in pancreatic cancer and radiotherapy
Mathias Tesson, Jennifer P. Morton
Disease Models & Mechanisms (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 3
The metabolic crosstalk between PIN1 and the tumour microenvironment
Isabella Caligiuri, Vincenzo Canzonieri, Tomochiro Asano, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 143-157
Open Access | Times Cited: 7
Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities
Ammar Sarwar, Man Zhu, Qi Su, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103858-103858
Closed Access | Times Cited: 10
Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
Heng Liang, Jiani Zhan, Yunqiu Chen, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 1
Nanomaterials Mediated Multimodal Combined Treatment for Cancer
Caiyun Wang, Qiuna Zhang, Mengyao Chen, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 16, pp. 1623-1641
Closed Access | Times Cited: 2
Oncometabolites in pancreatic cancer: Strategies and its implications
Arunima Maiti, Susmita Mondal, Shouvik Choudhury, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Page 1

Scroll to top